Company: CL
Filing Date: 2025-03-26
Form Type: DEF 14A
Source: 0001308179-25-000223
Chunk: 16

Company: COLGATE PALMOLIVE CO
Filing Date: 2025-03-26
Form: DEF 14A
Chunk 16
---
105,000 | -5 |     | 179,946 | -5 |     | 44,988 |    |     |        8,250 |    |     | 338,184 |
| Stephen I. Sadove(7) |     |    37,500 |    |     |       — |    |     |      — |    |     |        8,440 |    |     |  45,940 |

NOTES TO THE DIRECTOR COMPENSATION TABLE

| (1) | Consists                                                                                   
 of an annual retainer and lead director and committee chair retainers, as described above. |

| (2) | This                                                                                                                              
 column reflects the aggregate grant date fair value of stock awards granted to each non-employee director in 2024. The grant date 
 fair value of stock awards granted to each non-employee director in 2024 was $94.46 per share, based on the fair market value     
 of our Common Stock on the date of grant.                                                                                         |

| (3) | This                                                                                                                            
 column reflects the aggregate grant date fair value of stock option awards granted to each non-employee director in 2024. The   
 key terms of such stock options are as follows: (i) the exercise price is equal to the closing price of our Common Stock on the 
 date of grant; (ii) the term is eight years; and (iii) they vest in equal annual installments over three years.                 |

The grant date fair value of stock options granted to each non-employee director in 2024 was $20.44 per option. The estimated value of options is calculated using the Black-Scholes-Merton option pricing model (the “Black-Scholes model”). For a description of the assumptions used to calculate the amounts shown in this column, see Note 7 (“Capital Stock and Stock-Based Compensation Plans”) to our Consolidated Financial Statements included in our Annual Report on Form 10-K for the year ended December 31, 2024. The aggregate number of stock options outstanding for each non-employee director as of December 31, 2024 was as follows: Mr. Bilbrey—20,143; Mr. Cahill—20,143; Mr. Cahillane— 4,845; Ms. Edwards—17,370; Dr. Harris—20,143; Ms. Hund-Mejean—11,818; Ms. Nelson—11,216; Mr